NKGen Biotech
(OTC) NKGN
NKGen Biotech Financials at a Glance
Market Cap
$19.59M
Revenue (TTM)
$652.00K
Net Income (TTM)
$23.55M
EPS (TTM)
$-1.22
P/E Ratio
-0.12
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.15
Volume
2,118
Open
$0.06
Price
$0.15
Volume
2,118
Open
$0.06
Previous Close
$0.15
Daily Range
$0.06 - $0.15
52-Week Range
$0.00 - $0.46
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.15
Volume
2,118
Open
$0.06
Previous Close
$0.15
Daily Range
$0.06 - $0.15
52-Week Range
$0.00 - $0.46
NKGN News
NKGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NKGen Biotech
Industry
Biotechnology
Sector
Health CareEmployees
26
CEO
Paul Y. Song, MD, PhD
Website
www.nkgenbiotech.comHeadquarters
Santa Ana, CA 92705, US
NKGN Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-25%
Net Income Margin
-11%
Return on Equity
0%
Return on Capital
59%
Return on Assets
-47%
Earnings Yield
-8.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.59M
Shares Outstanding
130.60M
Volume
2.12K
Short Interest
0.00%
Avg. Volume
4.05K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$26.97M
EBITDA
$26.97M
Operating Cash Flow
$20.88M
Capital Expenditure
$0.00
Free Cash Flow
$20.88M
Cash & ST Invst.
$0.00
Total Debt
$0.00
NKGen Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$19.59M
N/A
Market Cap/Employee
$310.96K
N/A
Employees
63
N/A
Net Income
$15.35M
+385.2%
EBITDA
$16.24M
+507.3%
Quarterly Fundamentals
Net Cash
$38.19M
-72.2%
Accounts Receivable
$23.00K
-11.5%
Inventory
$0.00
N/A
Long Term Debt
$11.28M
+7.5%
Short Term Debt
$26.91M
+129.6%
Return on Assets
-47.13%
N/A
Return on Invested Capital
59.02%
N/A
Free Cash Flow
$2.85M
+29.3%
Operating Cash Flow
$2.80M
+30.6%